diphtheria n : acute contagious infection caused by the bacterium Corynebacterium diphtheriae; marked by the formation of a false membrane in the throat and other air passages causing difficulty in breathing

English

Noun

diphtheria

1. A highly infectious disease of the upper respiratory tract characterised by a sore throat, fever and causing difficulty in breathing. It is caused by a bacterium which produces a toxin that leads to inflammation of the heart and nervous system.

Derived terms

• diphtherial
• diphtheric
• diphtheritic

Translations

• Catalan: diftèria (ca)
• French: diphthérie (fr)
• German: Diphtherie (de)
• Spanish: difteria (es)

Diphtheria (Greek διφθερα (diphthera) — “pair of leather scrolls") is an upper respiratory tract illness characterized by sore throat, low fever, and an adherent membrane (a pseudomembrane) on the tonsils, pharynx, and/or nasal cavity. A milder form of diphtheria can be restricted to the skin. It is caused by Corynebacterium diphtheriae, an aerobic Gram-positive bacterium.

Diphtheria causes the progressive deterioration of myelin sheaths in the central and peripheral nervous system leading to degenerating motor control and loss of sensation. Diphtheria is a contagious disease spread by direct physical contact or breathing the aerosolized secretions of infected individuals. Once quite common, diphtheria has largely been eradicated in developed nations through widespread vaccination. In the United States for instance, there were 52 reported cases of diphtheria between 1980 and 2000; since 2000 there have only been five cases as the DPT (Diphtheria–Pertussis–Tetanus) vaccine is given to all school children. Boosters of the vaccine are recommended for adults since the benefits of the vaccine decrease with age without constant re-exposure; they are particularly recommended for those traveling to areas where the disease has not been eradicated.

History

In the 1920s there were an estimated 100,000 to 200,000 cases of diphtheria per year in the United States, causing 13,000 to 15,000 deaths.

One of the first effective treatments for diphtheria was discovered in the 1880s by U.S. physician Joseph O'Dwyer (1841-1898). O'Dwyer developed tubes that were inserted into the throat, and prevented victims from suffocating due to the membrane sheath that grows over and obstructs airways. In the 1890s, the German physician Emil von Behring developed an antitoxin that did not kill the bacteria, but neutralized the toxic poisons that the bacteria releases into the body. von Behring discovered that animal blood has antitoxins in and so he took the blood, removed the clotting agents and injected it into human patients. von Behring was awarded the first Nobel Prize in Medicine for his role in the discovery, and development of a serum therapy for diphtheria. (Americans William H. Park and Anna Wessels Williams; and Pasteur Institute scientists Emile Roux and Auguste Chaillou also independently developed diphtheria antitoxin in the 1890s.) The first successful vaccine for diphtheria was developed in 1913 by Behring. However, antibiotics against diphtheria were not available until the discovery and development of sulfa drugs following World War II.

The Schick test, invented between 1910 and 1911, is a test used to determine whether or not a person is susceptible to diphtheria. It was named after its inventor, Béla Schick (1877-1967), a Hungarian-born American pediatrician. A massive five-year campaign was coordinated by Dr. Schick. As a part of the campaign, 85 million pieces of literature were distributed by Metropolitan Life Insurance Company with an appeal to parents to "Save your child from diphtheria." A vaccine was developed in the next decade, and deaths began declining in earnest in 1924.http://www.healthsentinel.com/graphs.php?id=14&event=graphs_print_list_item

Mechanism

Diphtheria toxin catalyzes the ADP-ribosylation of, and inactivates, the elongation factor eEF-2.[6] In this way, it acts to inhibit translation during eukaryotic protein synthesis. The toxin enters the host cell and is hydrolysed by a trypsin-like protease to give a fragment with enzymatic activity. The toxin then transfers an ADP-ribose from NAD+ to a diphthamide residue, a modified histidine (amino acid), which is found within the EF-2 protein. EF-2 is needed for translocation of tRNA from the A-site to the P-site of the ribosome during traslation. The ADP-ribosylation is reversible by administering high concentrations of nicotinamide, one of the reaction products.

Signs and symptoms

The respiratory form has an incubation period of 2-5 days. The onset of disease is usually gradual. Symptoms include fatigue, fever, a mild sore throat and problems swallowing. Children infected have symptoms that include nausea, vomiting, chills, and a high fever, although some do not show symptoms until the infection has progressed further. In 10% of cases, patients experience neck swelling. These cases are associated with a higher risk of death.

In addition to symptoms at the site of infection (sore throat), the patient may experience more generalized symptoms, such as listlessness, pallor, and fast heart rate. These symptoms are caused by the toxin released by the bacterium. Low blood pressure may develop in these patients. Longer-term effects of the diphtheria toxin include cardiomyopathy and peripheral neuropathy (sensory type). The cutaneous form of diphtheria is often a secondary infection of a preexisting skin disease. Signs of cutaneous diphtheria infection develop an average of seven days after the appearance of the primary skin disease.

Diagnosis

The current definition of diphtheria used by the Centers for Disease Control and Prevention (CDC) is based on both laboratory and clinical criteria.

Laboratory criteria

• Isolation of Corynebacterium diphtheriae from a clinical specimen, or
• Histopathologic diagnosis of diphtheria.

Clinical criteria

• Upper respiratory tract illness with sore throat
• Low-grade fever, and
• An adherent pseudomembrane of the tonsil(s), pharynx, and/or nose.

Case classification

• Probable: a clinically compatible case that is not laboratory-confirmed and is not epidemiologically linked to a laboratory-confirmed case
• Confirmed: a clinically compatible case that is either laboratory-confirmed or epidemiologically linked to a laboratory-confirmed case

Empirical treatment should generally be started in a patient in whom suspicion of diphtheria is high.

Treatment

The disease may remain manageable, but in more severe cases lymph nodes in the neck may swell, and breathing and swallowing will be more difficult. People in this stage should seek immediate medical attention, as obstruction in the throat may require intubation or a tracheotomy. In addition, the hyper sensitivity of the larynx may cause cardiac arrest around the intubation. Diphtheria can also cause paralysis in the eye, neck, throat, or respiratory muscles. Patients with severe cases will be put in a hospital intensive care unit (ICU) and be given a diphtheria anti-toxin. Since antitoxin does not neutralize toxin that is already bound to tissues, delaying its administration is associated with an increase in mortality risk. Therefore, the decision to administer diphtheria antitoxin is based on clinical diagnosis, and should not await laboratory confirmation.

Antibiotics have not been demonstrated to affect healing of local infection in diphtheria patients treated with antitoxin. Antibiotics are used in patients or carriers to eradicate C. diphtheriae and prevent its transmission to others. The CDC recommends either:

• Erythromycin (orally or by injection) for 14 days (40 mg/kg per day with a maximum of 2 g/d), or
• Procaine penicillin G given intramuscularly for 14 days (300,000 U/d for patients weighing 10 kg). Patients with allergies to penicillin G or erythromycin can use rifampin or clindamycin.

Epidemiology

Diphtheria is a serious disease, with fatality rates between 5% and 10%. In children under 5 years and adults over 40 years, the fatality rate may be as much as 20%. Outbreaks, though very rare, still occur worldwide, even in developed nations. After the breakup of the former Soviet Union in the late 1980s, vaccination rates in its constituent countries fell so low that there was an explosion of diphtheria cases. In 1991 there were 2,000 cases of diphtheria in the USSR. By 1998, according to Red Cross estimates, there were as many as 200,000 cases in the Commonwealth of Independent States, with 5,000 deaths. This was so great an increase that diphtheria was cited in the Guinness Book of World Records as "most resurgent disease".

References

Further reading

• Holmes RK, Diphtheria and other corynebacterial infections. in Harrison's Principles of Internal Medicine, 16th Ed. (2005)
• Antitoxin dars 1735 and 1740." The William and Mary Quarterly, 3rd Ser., Vol 6, No 2. p. 338. See Also: Shulman, Stanford (2004) http://scholar.google.com/scholar?hl=en&lr=&safe=off&q=cache:FVEy_eca3ToJ:binf.gmu.edu/rkadoi/sysbio/PediatricInfectious.pdf+diphtheria+history+1735+and+1740 The History of Pediatric Infectious Diseases (Html by Google)] Pediatric Research. Vol. 55, No. 1

External links

African lethargy, Asiatic cholera, Chagres fever, German measles, Haverhill fever, acute articular rheumatism, ague, alkali disease, amebiasis, amebic dysentery, anthrax, bacillary dysentery, bastard measles, black death, black fever, blackwater fever, breakbone fever, brucellosis, bubonic plague, cachectic fever, cerebral rheumatism, chicken pox, cholera, cowpox, dandy fever, deer fly fever, dengue, dengue fever, dumdum fever, dysentery, elephantiasis, encephalitis lethargica, enteric fever, erysipelas, famine fever, five-day fever, flu, frambesia, glandular fever, grippe, hansenosis, hepatitis, herpes, herpes simplex, herpes zoster, histoplasmosis, hookworm, hydrophobia, infantile paralysis, infectious mononucleosis, inflammatory rheumatism, influenza, jail fever, jungle rot, kala azar, kissing disease, lepra, leprosy, leptospirosis, loa loa, loaiasis, lockjaw, madness, malaria, malarial fever, marsh fever, measles, meningitis, milzbrand, mumps, ornithosis, osteomyelitis, paratyphoid fever, parotitis, parrot fever, pertussis, pneumonia, polio, poliomyelitis, polyarthritis rheumatism, ponos, psittacosis, rabbit fever, rabies, rat-bite fever, relapsing fever, rheumatic fever, rickettsialpox, ringworm, rubella, rubeola, scarlatina, scarlet fever, schistosomiasis, septic sore throat, shingles, sleeping sickness, sleepy sickness, smallpox, snail fever, splenic fever, spotted fever, strep throat, swamp fever, tetanus, thrush, tinea, trench fever, trench mouth, tuberculosis, tularemia, typhoid, typhoid fever, typhus, typhus fever, undulant fever, vaccinia, varicella, variola, venereal disease, viral dysentery, whooping cough, yaws, yellow fever, yellow jack, zona, zoster